Quality Control Automation for Chronic Disease Management Devices

Devices used in chronic disease management, insulin pens, glucose monitors, and similar daily-use products, carry a quality bar that most consumer electronics never have to meet, because a fault isn't an inconvenience, it's a health risk. WEISS builds quality control directly into its automated assembly lines rather than treating it as a separate offline stage, using optical inspection systems that check components and sub-assemblies as they move through the line. This is layered on top of assembly and test processes already proven in insulin pen production, where the TR1100/20 and TC220 platforms combine assembly and testing in one sequence. For manufacturers of chronic disease management devices, that combination means defects are caught at the point they occur, not after a batch has already left the line.